Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.50
1.36 (2.71%)
At close: Aug 15, 2025, 2:51 PM

Anbio Biotechnology Class A Ordinary Shares Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023
Revenue
2.53M 6.32M 3.95M 3.31M
Cost of Revenue
390.51K 2.1M 2.26M 1.36M
Gross Profit
2.14M 4.23M 1.69M 1.94M
Operating Income
-1.74M 3.89M 583.74K 1.54M
Interest Income
215.47K 149.66K 160.06K 18.75K
Pretax Income
-1.32M 3.89M 792.93K 1.64M
Net Income
-1.32M 3.89M 792.93K 1.64M
Selling & General & Admin
3.52M 199.48K 962.08K 406.06K
Research & Development
353.47K 138.03K 145.7K n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
3.87M 337.5K 1.11M 406.06K
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-4.26M -2.43M -3.37M -1.77M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
42.29M 42.29M 42.29M 42.29M
Shares Outstanding (Diluted)
42.29M 42.29M 42.29M 42.29M
EPS (Basic)
-0.03 0.09 0.02 0.04
EPS (Diluted)
-0.03 0.09 0.02 0.04
EBITDA
-1.32M 3.89M 796.47K 1.65M
EBIT
-1.32M 3.89M 792.93K 1.64M
Depreciation & Amortization
n/a n/a 3.54K 9.49K